Adam R. Craig
Chairman
X4 Pharmaceuticals, Inc (XFOR)Equibles does not estimate personal net worth.
Get an email with a short summary when X4 Pharmaceuticals, Inc publishes a filing, an earnings call transcript or a press release.
Get XFOR alertsAbout Adam R. Craig
Adam R. Craig is recorded as Chairman at X4 Pharmaceuticals, Inc (XFOR). The newest filing on record that lists Adam R. Craig as Chairman at X4 Pharmaceuticals, Inc (XFOR) is dated March 20, 2026. The proxy statement of X4 Pharmaceuticals, Inc reports total compensation of $6,705,205 for Adam R. Craig in fiscal 2025, including a base salary of $179,629. X4 Pharmaceuticals, Inc is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at X4 Pharmaceuticals, Inc includes Adam Raymond Craig, M.D., Ph.D. (CEO, Chairman and Board Member), Michael Gray (CEO), Paula Ragan (CEO) and 7 others.
Affiliation history
-
Current
Start not stated–present
Last confirmed March 20, 2026
Company network
Leadership on record at X4 Pharmaceuticals, Inc
- Adam Raymond Craig, M.D., Ph.D. CEO, Chairman, Board Member
- Michael Gray CEO
- Paula Ragan CEO
- Adam Craig Chairman
- Dr. Craig Chairman, Board Member
- David H. Kirske CFO
- David Kirske CFO
- Mr. Kirske CFO
- John Volpone COO
- Mary DiBiase, Ph.D. COO
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | X4 Pharmaceuticals, Inc (XFOR) | M.D., Ph.D., M.B.A. Executive Chairman | $179,629 | $6,705,205 |
Recent activity
No call appearances or filed executive changes recorded yet.